MedPath

Expansion of Integrated AI Solution for Diabetic Retinopathy Screening in Thailand

Conditions
Type 1 or 2 diabetes mellitus patients who come for diabetic retinopathy screening
Diabetic Retinopathy, Screening, Deep Learning Algorithm, Human Grader
Registration Number
TCTR20220722004
Lead Sponsor
Health Systems Research Institute (HSRI)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
nknown
Sex
All
Target Recruitment
34500
Inclusion Criteria

1. Type 1 or 2 diabetes mellitus patients whose name are in primary hospital record 2. No full-time ophthalmologists in those primary hospital 3. Age more than or equal to 18 years 4. Eligible for fundus photo imaging at least 1 eye

Exclusion Criteria

1. Type 1 or 2 diabetes mellitus patients whose name are in primary hospital record that have full-time ophthalmologists 2. Patients who previously diagnosed with other causes of macular edema, for example, Age-related Macular Degeneration, Radiation Retinopathy, Retinal Vein Occlusion etc. 3. History of retinal laser or surgery 4. Other ocular diseases that require referral to ophthalmologists
5. Not eligible for fundus photo imaging for both eyes (any causes)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficiency and effectiveness of AI in diabetic retinopathy screening Throughout the whole period of study 1.Down time and failure rate of AI system 2. Referral adherance in AI group 3. Cost in development and implement of AI system
Secondary Outcome Measures
NameTimeMethod
Satisfaction of patients and health care personnel in AI-based screening At the end of study Questionnaire
© Copyright 2025. All Rights Reserved by MedPath